[Rapporto di ricerca] Il mercato del genoma digitale è stato valutato a 11.065,31 milioni di dollari nel 2019 e si prevede che raggiungerà i 20.812,81 milioni di dollari nel 2027; si prevede che crescerà a un CAGR dell'8,4% dal 2020 al 2027.
Il genoma digitale è un insieme digitale completo di materiale genetico presente in un organismo o in una cellula . La tecnologia del genoma digitale si occupa dei geni e delle loro funzioni per trovare le cause delle malattie croniche e anche per risolverle. La tecnologia è associata ai progressi che contribuiscono a rendere l’assistenza sanitaria più personale e più efficace per il trattamento. Inoltre, il genoma digitale rappresenta un modo più semplice per raccogliere informazioni sulla malattia cronica. La tecnologia viene utilizzata dai professionisti per osservare più da vicino le malattie genetiche, come il cancro. Il genoma digitale funge da supporto che consente l'accesso immediato a combinazioni di tratti per risolvere query personalizzate apparentemente infinite.
Regioni redditizie per il mercato del genoma digitale
Approfondimenti di mercato
Crescenti finanziamenti per la genomica
La tecnologia di sequenziamento genomico si sta rapidamente trasformando in applicazioni cliniche pratica, e l’implementazione della stessa nei sistemi sanitari è stata supportata da ingenti investimenti governativi, pari a circa 4 miliardi di dollari in almeno 14 paesi. Queste iniziative nazionali di medicina genomica stanno guidando un cambiamento trasformativo in condizioni di vita reale, affrontando contemporaneamente gli ostacoli all’implementazione e raccogliendo prove per un’adozione più ampia, guidando così la crescita del mercato. Inoltre, il Regno Unito ha annunciato il più grande progetto sul genoma del mondo come parte di una collaborazione pubblica e privata da 200 milioni di persone tra enti di beneficenza e aziende farmaceutiche. Il Regno Unito ha già sviluppato il più grande database di genomi al mondo attraverso il progetto 100.000 Genomes. Guidato da Innovate UK nell’ambito di UK Research and Innovation, il progetto finanzierà ricercatori e industria per combinare dati e prove del mondo reale provenienti dai servizi sanitari del Regno Unito e creare nuovi prodotti e servizi in grado di diagnosticare le malattie in modo efficiente. Inoltre, nel novembre 2018, Stilla Technologies ha annunciato di aver completato un round di finanziamento di serie A da 18,3 milioni di dollari (€16 milioni) guidato da Illumina Ventures. L'azienda utilizzerà i fondi per commercializzare il suo sistema PCR digitale Naica e sviluppare applicazioni cliniche.
Grazie ai continui finanziamenti da parte dei produttori e del governo nel campo della genomica, Si prevede che il mercato del genoma digitale assisterà a una crescita durante il periodo di previsione.
Approfondimenti basati sul prodotto
Basati sul prodotto, il mercato del genoma digitale è segmentato in analisi del DNA/RNA, chip di sequenziamento, strumenti di sequenziamento e analisi, strumenti di preparazione dei campioni, software di sequenziamento e analisi. Il segmento degli strumenti di sequenziamento e analisi ha detenuto la quota maggiore del mercato nel 2019, grazie a vantaggi quali la crescente adozione del sequenziamento degli strumenti di analisi da parte delle aziende farmaceutiche e biofarmaceutiche nelle economie avanzate. Inoltre, le aziende si stanno concentrando sulla fornitura di strumenti di qualità superiore ai centri di ricerca e alle aziende farmaceutiche coinvolte nello sviluppo di terapie per le malattie genetiche. Ad esempio, Thermo Fisher Scientific ha annunciato il lancio del suo Ion Torrent Genexus System, la prima piattaforma di sequenziamento di nuova generazione (NGS) completamente integrata dotata di un flusso di lavoro automatizzato dal campione al report che fornisce risultati economicamente in un solo giorno.
Mercato globale del genoma digitale, per prodotto - 2019 e 2027
Approfondimenti basati sull'applicazione
In base all'applicazione, il mercato del genoma digitale è segmentato in diagnostica, ricerca agricola e accademica, scoperta di farmaci, medicina personalizzata e altre applicazioni. Nel 2019, il segmento della diagnostica deteneva la quota maggiore del mercato globale del genoma digitale grazie a fattori quali il lancio di prodotti diagnostici innovativi, i crescenti investimenti nelle tecnologie genomiche e l’espansione delle capacità del genoma digitale nelle applicazioni diagnostiche. Ad esempio, nell'aprile 2020, Personal Genome Diagnostics, la società impegnata nello sviluppo di un nuovo kit diagnostico per la profilazione genomica di diversi tumori, ha ricevuto l'approvazione della FDA per il suo test completo sui tessuti PGDx elio.
< /p>
Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato del genoma digitale è segmentato in laboratori diagnostici e forensi, istituti di ricerca accademica, ospedali e altri utenti finali. Il segmento dei laboratori di diagnostica e forense ha detenuto la quota maggiore del mercato nel 2019, a causa della crescente enfasi sull’adozione di genomi digitali nei laboratori di diagnostica e forense. Inoltre, il recente progresso tecnologico aiuterà a risolvere più casi in un periodo di tempo più breve e produrrà piste investigative per casi che avrebbero raggiunto vicoli ciechi e offrirà opportunità redditizie durante il periodo di previsione. Ad esempio, la tecnologia Illumina SBS, il sistema MiSeq FGx, è il primo sistema NGS progettato specificamente per applicazioni genomiche forensi.
Approfondimenti strategici
Il lancio dei prodotti e la strategia di espansione sono comunemente adottati dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Questa strategia è più comunemente adottata dagli operatori del mercato al fine di espandere il proprio portafoglio di prodotti.
Gli operatori del mercato che operano nel mercato del genoma digitale hanno adottato la strategia dell'innovazione del prodotto per soddisfare la mutevole domanda dei clienti in tutto il mondo, che consente inoltre ai giocatori di mantenere il proprio marchio a livello globale.
Mercato del genoma digitale: – Per prodotto
- Strumenti di sequenziamento e analisi
- Analisi di DNA/RNA
- Chip di sequenziamento
- Strumenti per la preparazione dei campioni,
- Software di sequenziamento e analisi
Mercato del genoma digitale: Per applicazione
- Diagnostica
- Agricola
- Ricerca accademica
- Scoperta di farmaci
- Medicina personalizzata
- Altre applicazioni
Mercato del genoma digitale: – Per utente finale
- Laboratori diagnostici e forensi
- Istituti di ricerca accademici
- Ospedali
- Altro utente finale < /ul>
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- America del Sud (SAM)
- Brasile
- Argentina
- Resto della SAM
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- QIAGEN
- GenomeMe
- NanoString Technologies, Inc.
- BD
- bioMerieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc.
Mercato del genoma digitale– Per area geografica
Profili aziendali
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Digital genome is a technology which deals with the genes and their functions to help to find the causes behind the chronic diseases and also to fix them. Digital genome is a complete digital set of genetic material that present in an organism or a cell. The technology is associated with the advancements that helps to make healthcare more personal and more effective for the treatment. Moreover, the digital genome is an easier way to gathering the information about the chronic disease. The technology is used by the professionals to get a closer look of genetic composed diseases, such as cancer. A digital genome act as a supporter that enables instant access to trait combinations to solve apparently endless custom queries.
The factors that are driving growth of the market are increasing prevalence of increasing prevalence of chronic diseases, and growing funding for genomics. Moreover, increasing technological advancement in digital genome field are offering lucrative opportunities for the growth of the market.
The digital genome market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC., F. HOFFMANN-LA ROCHE LTD, Illumina, Inc., QIAGEN, GenomeMe, NanoString Technologies, Inc., BD, bioMerieux SA, GenMark Diagnostics, Inc., and Perkin Elmer, Inc. among others.
The List of Companies - Digital Genome Market
- THERMO FISHER SCIENTIFIC INC.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- QIAGEN
- GenomeMe
- NanoString Technologies, Inc.
- BD
- bioMerieux SA
- GenMark Diagnostics, Inc.
- Perkin Elmer, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
May 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
May 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
May 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)